Atlas Trials

Expanded Treatment Prot of Panobinostat in Combo w/ Bortez and Dex in Pts w/ Relapsed and/or Refractory Multiple Myeloma

Clinical trial NCT02204553 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT02204553
Sponsor
Novartis Pharmaceuticals
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Multiple Myeloma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.